Drug developer City Therapeutics files for US IPO as biotech listings surge

City Therapeutics filed for a US IPO amid a biotech listing surge, planning to list on Nasdaq under the symbol "CTY." The company develops RNA-based drugs for rare diseases and secured $238.8 million in funding prior to this offering.